Clinical Trials Browser

Adjustment Disorders, Amyotrophic Lateral Sclerosis, Anxiety Disorders, Depression, Multiple Sclerosis, Neoplasms, Idiopathic Pulmonary Fibrosis

Triple Negative Breast Neoplasms

Ovarian Neoplasms

Advance Solid Tumors

Solid Tumors

Multiple Myeloma

Triple Negative Breast Neoplasms

Advanced Lung Carcinoma

Advanced Solid Tumors

Leukemia, Myeloid, Acute

Advanced Malignant Solid Tumor

Advanced Solid Tumors

Advanced Malignant Solid Tumor

mCRPC (Metastatic Castration-resistant Prostate Cancer)

Advanced Solid Tumors Cancer

Biliary Tract Neoplasms

Uterine Cervical Neoplasms

Advanced Solid Tumor

Small Cell Lung Carcinoma

Advanced Solid Tumour

Lymphoma, Large B-Cell, Diffuse

Biliary Tract Neoplasms

Advanced or Metastatic Solid Tumors

Multiple Myeloma

HER2-positive Breast Cancer

Unresectable Locally Recurrent Breast Cancer

Clinical Trials

RE104 Safety and Efficacy Study in Adjustment Disorder in Cancer and Other Medical Illnesses

A Study of BEBT-209 Plus Chemotherapy in Patients With Locally Advanced or Metastatic Triple-Negative Breast Cancer

A Study of SHR-A1811 in Subjects With Ovarian Cancer

A First-in-Human Study of ALK-N001 for Injection in Patients With Advanced Solid Tumors

A I/II Phase Clinical Study to Evaluate the Safety and Efficacy of RC288 in the Treatment of Solid Tumors

A Clinical Study of SHR-9539 in Patients With Multiple Myeloma

A Phase III Study of JSKN016 Versus Treatment of Physician's Choice in Patients With Triple-Negative Breast Cancer Who Have Failed Standard of Care

A Clinical Study of TQB3616 Capsules Combined With Anlotinib Hydrochloride Capsules or Standard Chemotherapy Second-line and Above in the Treatment of Advanced Lung Cancer

To Evaluate the Safety, Tolerance and Pharmacokinetics of BAT8007 for Injection in Patients With Advanced Solid Tumors

L-Annamycin for Injection in Combination With Cytarabine Injection as Second Line Therapy for Remission Induction in Adult Subjects With Refractory/Relapsed AML

A Study of MHB009C in Patients With Advanced Solid Tumors

A Phase Ib/II Study Evaluating Injectable ALK-N001 in Patients With Advanced Solid Tumors

A Study of MHB042C in Patients With Advanced Solid Tumors

A Study of MHB048C in Patients With Advanced Solid Tumors

First-In-Human Study of KHN922 for Injection

A Study of TQB2102 for Injection in the Treatment of HER2-positive Biliary Tract Cancer

A Study of SHR-A2102 Versus Investigator's Choice of Chemotherapy in Patients With Platinum-based Chemotherapy and PD-(L)1 Inhibitor Treatment Failed Recurrent or Metastatic Cervical Cancer

Clinical Studies of TQB2930 Injection for the Treatment of Advanced Solid Tumors

SKB500 Combinations in Patients With Small Cell Lung Cancer

A Phase Ib/II Clinical Trial of LBL-007 Combined With Tislelizumab in the Treatment of Malignant Tumors

A Phase II Clinical Trial of LBL-024 Combination Drug in Patients With Advanced Solid Tumour[Substudy 04]

A Phase III Study of HMPL-760 Plus R-GemOx VS Placebo Plus R-GemOx in Relapsed/Refractory DLBCL

A Study of SHR-A1904 in Previous Systemic Treatment Failed Biliary Tract Cancer

Assessment of Safety, Tolerability and Pharmacokinetics With BAT8010 for Injection in Advanced Malignant Solid Tumors Patients

MAGNETISMM-5

A Clinical Study of Neoadjuvant Treatment With TQB2102 for Injection for Human Epidermal Growth Factor Receptor 2 (HER2) Positive Breast Cancer

A Trial of Trastuzumab Rezetecan in Unresectable Locally Recurrent/Metastatic Breast Cancer